Sort
17,288 grants matching “multiple sclerosis”
Combating chronic neuroinflammatory disorders by targeting NAC1
$225,279Jianxun Jim Song · Texas A&M University Health Science Ctr · R21 · FY2022 · AI
Antiviral Therapy for Polyomavirus Infection
$225,140Aron Lukacher · Emory University · R21 · FY2008 · AI
Multiple Sclerosis Study
$225,113Stephen L Hauser · University Of California, San Francisco · U19 · FY2006 · AI
Quantitative Image Analysis Techniques for Optic Nerve Disease
$225,089Bennett A. Landman · Vanderbilt University · R21 · FY2014 · EY
Neurorestorative Strategy for Diabetic Peripheral Neuropathy
$225,067Feng-Qiao Li · Cognosci, Inc. · R43 · FY2013 · DK
Development of targeted, safe and effective drugs against pancreatic ductal adenocarcinoma (PDAC) by leveraging a novel, comprehensive, computational drug discovery approach
$225,030Timothy S Heuer · Twoxar, Inc. · R43 · FY2018 · CA
CD24 and thymic generation of myelin antigen specific T cells
$225,000Xue-Feng Bai · Ohio State University · R21 · FY2008 · AI
Jamboxx: Interactive Respiratory Therapy through Music and Gaming
$225,000Michael Dicesare · My Music Machines, Inc. · R42 · FY2016 · HL
Cannabinoid Regulation of Basal Ganglia Glutamate and GABA
$225,000Scott M Rawls · Temple Univ Of The Commonwealth · R15 · FY2007 · DA
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immu
$225,000Rosh Chandraratna · Io Therapeutics, Inc. · R43 · FY2014 · AI
Can beta-lactam antibiotics decrease morphine physical dependence?
$225,000Scott M Rawls · Temple Univ Of The Commonwealth · R15 · FY2008 · DA
Non-traditional Cardiovascular Risk Factors in DM type 2
$225,000Phoenix Va Health Care System · R01 · FY2004 · HL
STTR Phase I: Human Microphysiological Model for Assaying the Efficacy of Drugs for Myelin Disorders
$225,000Jabe L Curley · Axosim Technologies Llc · · FY2016 · TIP
A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier
$225,000Thomas Neumann · Nortis, Inc. · R44 · FY2015 · NS
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery
$225,000Robert G Lowery · Bellbrook Labs, Llc · R41 · FY2015 · NS
Non-traditional Cardiovascular Risk Factors in DM type 2
$225,000Phoenix Va Health Care System · R01 · FY2001 · HL
Development of a commercial Magnetic Particle Imaging platform for the detection and quantification of localized inflammation in cancer
$225,000Patrick Goodwill · Magnetic Insight, Inc. · R43 · FY2019 · CA
Identification of Novel Nuclear RGS10 Binding Partners
$225,000Shelley B Hooks Pence · University Of Georgia · R21 · FY2017 · NS
Non-traditional Cardiovascular Risk Factors in DM type 2
$225,000Phoenix Va Health Care System · R01 · FY2003 · HL
Complex 3-Dimensional in Vitro Human Skin Tissue Models for Scleroderma
$225,000Michael W Fanger · Celdara Medical, Llc · R43 · FY2017 · AR
SBIR Phase I: Low-cost needle guidance system for bedside lumbar puncture
$225,000Cassidy Wang · Ethos Medical, Inc. · · FY2020 · TIP
Development of a novel accurate therapy for Multiple Sclerosis
$225,000Gaddiel Galarza-Munoz · Autoimmunity Biologic Solutions, Inc. · R41 · FY2019 · AI
Novel Peptide MPO Inhibitors for Treating Atherosclerosis
$225,000Kirkwood A Pritchard · Medical College Of Wisconsin · R21 · FY2012 · HL
SBIR Phase I: Development of a Wearable Retinal Imaging Device for Improved Monitoring of Multiple Sclerosis at Home
$225,000Samantha I Scott · Junebrain, Inc. · · FY2018 · TIP
High Resolution Microbiome Profiling System
$225,000Mark David Driscoll · Intus Biosciences Llc · R43 · FY2017 · DA